Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy

Area of Science:

• Oncolytic virotherapy
• Cancer biology
• Virology

Background:

• Oncolytic adenovirus therapy shows promise for cancer treatment, but its success hinges on adenovirus receptor expression on tumor cells.
• Different adenovirus serotypes bind to distinct receptors, with variable expression across tumor types.
• Pre-existing immunity to common adenoviruses like human adenovirus species C type 5 (HAdV-C5) limits therapeutic effectiveness.

Purpose of the Study:

• To review known human adenovirus receptors and their differential expression on tumor cells versus healthy tissues.
• To explore mechanisms of adenovirus receptor regulation (up/downregulation) in the context of cancer and treatment.
• To examine the role of adenovirus receptors in viral spread and their potential as targets for combination therapy.

Main Methods:

• Literature review of adenovirus-receptor interactions and expression patterns.
• Analysis of receptor regulation mechanisms in tumor cells.
• Evaluation of receptor utility in oncolytic virotherapy and viral dissemination.

Main Results:

• Adenovirus receptor expression varies significantly between tumor types and can be altered by anticancer treatments.
• Mechanisms of receptor modulation offer potential targets for enhancing oncolytic adenovirus therapy.
• Adenovirus receptors play a crucial role in viral spread, potentially beyond initial cell entry.

Conclusions:

• Knowledge of adenovirus receptor expression is critical for selecting optimal adenovirus vectors for specific cancer types.
• Targeting receptor regulation could improve oncolytic adenovirus therapy efficacy.
• Further research into receptor function in viral spread is needed to maximize therapeutic potential.